Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Major AI-Pharma Partnerships And Investments Of 2024: A Strategic Overview

Feb 24 2025

• By David Wild

(Shutterstock)

Related Content

Lilly And Novartis Are First Pharma Partners For Alphabet’s Isomorphic In Drug Discovery

Jan 08 2024

Deal Watch: Roche Partners With Dyno On AAV-Delivered Gene Therapies

Oct 14 2020

Xaira Launches With $1bn-Plus And End-To-End AI Strategy

Apr 25 2024

Deal Watch: Bristol Accesses Tech Platforms From SyntheX, Autolus

Oct 05 2022

GSK Looks To Identify Novel Interventions In Parkinson’s With Vesalius

Nov 12 2024

Related Companies

GSK plc

Eli Lilly and Company

Novartis AG

Isomorphic Labs

Dyno Therapeutics, Inc.

Roche Holding AG

Xaira Therapeutics, Inc.

Recursion Pharmaceuticals, Inc.

VantAI

Vesalius Therapeutics

Relation Therapeutics

Novo Nordisk A/S

Cellarity

Additional Topics

Artificial Intelligence Deals Financing VC Playbook

More from Deal-Making

More from Business Strategy

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window